BrainStorm Cell Therapeutics Inc. Demonstrates Efficacy in an Experimental Model of Parkinson’s Disease- Paper Published in "Stem Cells and Development"
NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--Today’s on-line publication by scientists working with BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), demonstrates that human-derived adult Stem Cells may be induced to differentiate in vitro into neural-like cells and, once injected into the brain, improve impaired motor behavior in an experimental model of Parkinson's disease.